Earnings Release

GENESIS HEALTHCARE REPORTS SECOND QUARTER 2017 RESULTS
8/8/2017

FOR IMMEDIATE RELEASE 

 

Genesis HealthCare Contact:  

Investor Relations                                           

610-925-2000


GENESIS HEALTHCARE

REPORTS SECOND QUARTER 2017 RESULTS

 

 

KENNETT SQUARE, PA – (August 8, 2017) – Genesis HealthCare (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results for the second quarter ended June 30, 2017. 

 


Second Quarter 2017 Results

 

  • US GAAP revenue in the second quarter of 2017 was $1.34 billion compared to $1.44 billion in the prior year quarter;

  • US GAAP net loss attributable to Genesis HealthCare, Inc. in the second quarter of 2017 was $65.2 million compared to $23.0 million in the prior year quarter;

     

  • Adjusted EBITDAR in the second quarter of 2017 was $175.4 million compared to $189.4 million in the prior year quarter; and

  • Adjusted EBITDA in the second quarter of 2017 was $137.1 million compared to $152.4 million in the prior year quarter.

     

“We delivered a solid quarter despite persistent headwinds and we continued to execute on our plan to divest non-strategic assets, which will allow for increased focus on markets where we have geographic density,” noted George V. Hager, Jr., Chief Executive Officer of Genesis.  “During the quarter, our dedicated team of professionals remained focused on the areas of the business we can control.  We effectively managed labor and overhead costs, realized record gain share dollars under the Model 3 BPCI program, generated strong operating cash flows and maintained year-over-year Adjusted EBITDAR margins.”


Click here for the entire release.